Questions And Answer | Back Directory | [Description]
Glofitamab is part of Genentech's industry-leading CD20xCD3 bispecific antibody development program, which aims to address the diverse needs and preferences of people with blood cancers. |
|
Company Name: |
Biolab Reagents
|
Tel: |
027-65279366 18162686757 |
Website: |
www.biolabreagent.com/ |
|